Global Prostate Cancer Drugs Sales Market Report 2017

Table of Contents

Global Prostate Cancer Drugs Sales Market Report 2017
1 Prostate Cancer Drugs Market Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs by Product Category
1.2.1 Global Prostate Cancer Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Prostate Cancer Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Hormonal Therapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Targeted Therapy
1.3 Global Prostate Cancer Drugs Market by Application/End Users
1.3.1 Global Prostate Cancer Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Prostate Cancer Drugs Market by Region
1.4.1 Global Prostate Cancer Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Prostate Cancer Drugs Status and Prospect (2012-2022)
1.4.3 China Prostate Cancer Drugs Status and Prospect (2012-2022)
1.4.4 Europe Prostate Cancer Drugs Status and Prospect (2012-2022)
1.4.5 Japan Prostate Cancer Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Prostate Cancer Drugs Status and Prospect (2012-2022)
1.4.7 India Prostate Cancer Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Prostate Cancer Drugs (2012-2022)
1.5.1 Global Prostate Cancer Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Prostate Cancer Drugs Revenue and Growth Rate (2012-2022)

2 Global Prostate Cancer Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Prostate Cancer Drugs Market Competition by Players/Suppliers
2.1.1 Global Prostate Cancer Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Prostate Cancer Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Prostate Cancer Drugs (Volume and Value) by Type
2.2.1 Global Prostate Cancer Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Prostate Cancer Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Prostate Cancer Drugs (Volume and Value) by Region
2.3.1 Global Prostate Cancer Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Prostate Cancer Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Prostate Cancer Drugs (Volume) by Application

3 United States Prostate Cancer Drugs (Volume, Value and Sales Price)
3.1 United States Prostate Cancer Drugs Sales and Value (2012-2017)
3.1.1 United States Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Prostate Cancer Drugs Sales Price Trend (2012-2017)
3.2 United States Prostate Cancer Drugs Sales Volume and Market Share by Players
3.3 United States Prostate Cancer Drugs Sales Volume and Market Share by Type
3.4 United States Prostate Cancer Drugs Sales Volume and Market Share by Application

4 China Prostate Cancer Drugs (Volume, Value and Sales Price)
4.1 China Prostate Cancer Drugs Sales and Value (2012-2017)
4.1.1 China Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Prostate Cancer Drugs Sales Price Trend (2012-2017)
4.2 China Prostate Cancer Drugs Sales Volume and Market Share by Players
4.3 China Prostate Cancer Drugs Sales Volume and Market Share by Type
4.4 China Prostate Cancer Drugs Sales Volume and Market Share by Application

5 Europe Prostate Cancer Drugs (Volume, Value and Sales Price)
5.1 Europe Prostate Cancer Drugs Sales and Value (2012-2017)
5.1.1 Europe Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Prostate Cancer Drugs Sales Price Trend (2012-2017)
5.2 Europe Prostate Cancer Drugs Sales Volume and Market Share by Players
5.3 Europe Prostate Cancer Drugs Sales Volume and Market Share by Type
5.4 Europe Prostate Cancer Drugs Sales Volume and Market Share by Application

6 Japan Prostate Cancer Drugs (Volume, Value and Sales Price)
6.1 Japan Prostate Cancer Drugs Sales and Value (2012-2017)
6.1.1 Japan Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Prostate Cancer Drugs Sales Price Trend (2012-2017)
6.2 Japan Prostate Cancer Drugs Sales Volume and Market Share by Players
6.3 Japan Prostate Cancer Drugs Sales Volume and Market Share by Type
6.4 Japan Prostate Cancer Drugs Sales Volume and Market Share by Application

7 Southeast Asia Prostate Cancer Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Prostate Cancer Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Prostate Cancer Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Prostate Cancer Drugs Sales Volume and Market Share by Application

8 India Prostate Cancer Drugs (Volume, Value and Sales Price)
8.1 India Prostate Cancer Drugs Sales and Value (2012-2017)
8.1.1 India Prostate Cancer Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Prostate Cancer Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Prostate Cancer Drugs Sales Price Trend (2012-2017)
8.2 India Prostate Cancer Drugs Sales Volume and Market Share by Players
8.3 India Prostate Cancer Drugs Sales Volume and Market Share by Type
8.4 India Prostate Cancer Drugs Sales Volume and Market Share by Application

9 Global Prostate Cancer Drugs Players/Suppliers Profiles and Sales Data
9.1 AbbVie
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Prostate Cancer Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 AbbVie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Astellas Pharma
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Prostate Cancer Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Astra Zeneca
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Prostate Cancer Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Johnson & Johnson
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Prostate Cancer Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Johnson & Johnson Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sanofi
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Prostate Cancer Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 GlaxoSmithKline
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Prostate Cancer Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 GlaxoSmithKline Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Merck Group
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Prostate Cancer Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck Group Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Novartis
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Prostate Cancer Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Novartis Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Amgen
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Prostate Cancer Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Bayer HealthCare
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Prostate Cancer Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Bayer HealthCare Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Ferring Pharmaceutical
9.12 Janssen Pharmaceuticals
9.13 Endo Pharmaceuticals
9.14 BMS
9.15 Takeda Pharmaceuticals
9.16 Northwest Biotherapeutics
9.17 Teva Pharmaceutical
9.18 Boehringer Ingelheim
9.19 Foresee Pharmaceuticals
9.20 Tokai Pharmaceuticals
9.21 Spectrum Pharmaceuticals

10 Prostate Cancer Drugs Maufacturing Cost Analysis
10.1 Prostate Cancer Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Prostate Cancer Drugs
10.3 Manufacturing Process Analysis of Prostate Cancer Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Prostate Cancer Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Prostate Cancer Drugs Market Forecast (2017-2022)
14.1 Global Prostate Cancer Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Prostate Cancer Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Prostate Cancer Drugs Price and Trend Forecast (2017-2022)
14.2 Global Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Prostate Cancer Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Prostate Cancer Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Prostate Cancer Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Prostate Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Prostate Cancer Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Prostate Cancer Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Prostate Cancer Drugs Price Forecast by Type (2017-2022)
14.4 Global Prostate Cancer Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Prostate Cancer Drugs
Figure Global Prostate Cancer Drugs Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Prostate Cancer Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Hormonal Therapy Product Picture
Figure Chemotherapy Product Picture
Figure Immunotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Global Prostate Cancer Drugs Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Prostate Cancer Drugs by Application in 2016
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Prostate Cancer Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Prostate Cancer Drugs Sales Volume (K Pcs) (2012-2017)
Table Global Prostate Cancer Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Prostate Cancer Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Prostate Cancer Drugs Sales Share by Players/Suppliers
Figure 2017 Prostate Cancer Drugs Sales Share by Players/Suppliers
Figure Global Prostate Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Prostate Cancer Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Prostate Cancer Drugs Revenue Share by Players
Table 2017 Global Prostate Cancer Drugs Revenue Share by Players
Table Global Prostate Cancer Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Prostate Cancer Drugs Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure Global Prostate Cancer Drugs Sales Growth Rate by Type (2012-2017)
Table Global Prostate Cancer Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2012-2017)
Figure Global Prostate Cancer Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Prostate Cancer Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Region (2012-2017)
Figure Global Prostate Cancer Drugs Sales Growth Rate by Region in 2016
Table Global Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Region (2012-2017)
Figure Global Prostate Cancer Drugs Revenue Growth Rate by Region in 2016
Table Global Prostate Cancer Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Prostate Cancer Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Prostate Cancer Drugs by Region (2012-2017)
Figure Global Prostate Cancer Drugs Revenue Market Share by Region in 2016
Table Global Prostate Cancer Drugs Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Prostate Cancer Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Prostate Cancer Drugs by Application (2012-2017)
Figure Global Prostate Cancer Drugs Sales Market Share by Application (2012-2017)
Figure United States Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Prostate Cancer Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table United States Prostate Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Prostate Cancer Drugs Sales Volume Market Share by Players in 2016
Table United States Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table United States Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table United States Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table United States Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure China Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table China Prostate Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Prostate Cancer Drugs Sales Volume Market Share by Players in 2016
Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table China Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table China Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table China Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Europe Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Prostate Cancer Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Prostate Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Prostate Cancer Drugs Sales Volume Market Share by Players in 2016
Table Europe Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Europe Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Japan Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Players in 2016
Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Japan Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Figure India Prostate Cancer Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Prostate Cancer Drugs Sales Price (USD/Pcs) Trend (2012-2017)
Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Players (2012-2017)
Table India Prostate Cancer Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Prostate Cancer Drugs Sales Volume Market Share by Players in 2016
Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Type (2012-2017)
Table India Prostate Cancer Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Prostate Cancer Drugs Sales Volume Market Share by Type in 2016
Table India Prostate Cancer Drugs Sales Volume (K Pcs) by Application (2012-2017)
Table India Prostate Cancer Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Prostate Cancer Drugs Sales Volume Market Share by Application in 2016
Table AbbVie Basic Information List
Table AbbVie Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure AbbVie Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure AbbVie Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Astellas Pharma Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Astellas Pharma Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Astra Zeneca Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Astra Zeneca Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Johnson & Johnson Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Sanofi Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Merck Group Basic Information List
Table Merck Group Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Group Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Merck Group Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Merck Group Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Novartis Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Novartis Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Amgen Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Amgen Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Prostate Cancer Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Prostate Cancer Drugs Sales Global Market Share (2012-2017
Figure Bayer HealthCare Prostate Cancer Drugs Revenue Global Market Share (2012-2017)
Table Ferring Pharmaceutical Basic Information List
Table Janssen Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Basic Information List
Table BMS Basic Information List
Table Takeda Pharmaceuticals Basic Information List
Table Northwest Biotherapeutics Basic Information List
Table Teva Pharmaceutical Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Foresee Pharmaceuticals Basic Information List
Table Tokai Pharmaceuticals Basic Information List
Table Spectrum Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Players in 2016
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure Global Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Prostate Cancer Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Prostate Cancer Drugs Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Prostate Cancer Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Prostate Cancer Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Prostate Cancer Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Prostate Cancer Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Prostate Cancer Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Prostate Cancer Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Prostate Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Prostate Cancer Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Prostate Cancer Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Prostate Cancer Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Prostate Cancer Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Prostate Cancer Drugs Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Prostate Cancer Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Prostate Cancer Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.